[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.54.109. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Commentary
July 12, 1999

National Recommendations for the Pharmacological Treatment of HypertensionShould They Be Revised?

Arch Intern Med. 1999;159(13):1403-1406. doi:10.1001/archinte.159.13.1403

SINCE PUBLICATION of the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) in the November 24, 1997, issue of the ARCHIVES,1 several long-term morbidity and mortality trials and several comparative medication studies have been published. It is of interest to review the rationale for the JNC VI recommendations and discuss possible revisions that may be indicated on the basis of data from these new trials.

First Page Preview View Large
First page PDF preview
First page PDF preview
×